Page last updated: 2024-09-03

jolkinolide b and B16 Melanoma

jolkinolide b has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, C; Han, J; Li, D; Wang, B; Yan, X; Yu, L; Zheng, Q1

Other Studies

1 other study(ies) available for jolkinolide b and B16 Melanoma

ArticleYear
Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis.
    Scientific reports, 2016, 10-31, Volume: 6

    Topics: Adenosine Triphosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Euphorbia; Glucose Transporter Type 1; Glucose Transporter Type 3; Glucose Transporter Type 4; Glycolysis; Hexokinase; Melanoma, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Plant Roots; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Transplantation, Homologous

2016